Health and Family Welfare Government Departments Closing in 6 days TDR #56009448

Tender For T.E.NO.GMSCL/D-791/RC/2026-27TABLET CAPSULE,INJECTION,MISSELENEOUS ITEMS (74 ITEMS)

Issued by Government Departments · Gandhinagar, Gujarat
Tender Value
Ref. Documents
Estimated cost
Bid Submission
07 Aug 2026
6 days left
EMD
Ref. Documents
Bank guarantee accepted
Document Fee
17700
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
Gandhinagar → Gujarat
EMD Exemption
Not Available
Quantity
Not Available

Project Description

T.E.NO.GMSCL/D-791/RC/2026-27 TABLET CAPSULE,INJECTION,MISSELENEOUS ITEMS (74 ITEMS)- nepafenac eyedrops 0.3percent w/v (bak free), fluticasone nasal spray 0.05percent w/v, polymyxin-b ear drops 10,000 units/ml, diclofenac patch 100 mg, ketoralac patch 30mg (transdermal), amoxicillin potassium clavulanate 228.5mg/5ml syrup (30ml), amoxycillin (400mg/5ml) plusclavulanic acid (57mg/5ml) drops, eye drop brinzolamide 1percent w/v and timolol 0.5percent w/v, lotepredenol etabonate eyedrops 0.5percent w/v, sodium chloride 5percent eye drops w/v, chlor henicol 1percent w/w, polymixin b sulphate 5000iu, dexamethasone sodium phosphate 0.1percentw/w eye ointment, eye drop brimonidine 0.1percent w/v, sodium chromoglycate eyedrops 4percent w/v, azithromycin opthalmic ointment 1percent w/w 5gm, clindamycin cream, sodium phosphate (proctolysis ) enema 100 ml, distilled water for humidifier, respules formoterol fumarate dihydrate 20 mcg plusmicronised budesonide 0.5 mg, levosalbutamol inhalation solution (0.63 mg per 2.5 ml), levosalbutamol inhalation solution (1.25 mg), levosalbutamol metered dose inhaler (50 mcg ), levosalbutamol dry powder inhaler (100 mcg), budesonide 400 mcg dry powder inhaler, furosemide drops, tablets isoxsuprine 10mg, tablet artesunate, pyrimethamine andsulphadoxine 150 mg plus 25 mg plus 500 mg (2) (9-14 years), tablet linagliptin 2.5 mg, tablet sitagliptin 50 mg, sti/ rti colour coded drug kit-8(tablet cefixime 800 mg stat dose and tab. doxycycline 100 mg), tablet pirfenidone 200 mg, tablet pirfenidone 400 mg, tablet nintendanib 100 mg, tablet nintendanib 150 mg, tablet darunavir 600mg, tablet dolutegravir 50mg, tablet dolutegravir 10mg, tablet dolutegravir 50mg +lamivudine 300mg +tenofovir 300mg, tablet thiocochicoside 8mg, tablet piroxicam 20mg, tablet mefenamic acid 500 mg, tablet mycophenolate 250 mg, diclofenec sodium suppository 25 mg, tablet ketoralac 10 mg, doxylamine and vitamin b6 (pyridoxine), tablet methylcobalamine sublingual 1500 mcg, tablet cilostazol 50 mg, tablet prednisolone 40 mg, micropized progesterone sustain released tablets 300mg, tablet ferrous bisglycinate 25 mg, liposomal iron pyrophosphate 30mg with vitamin c 35 mg, vitamin b12 0.5 mcg, folic acid 570 mcg, glycopyronium 25microgram per 2 ml, diclofenec suppository 100 mg, injection isoxsuprine hcl, 5 mg/ml, 2 ml , meningococcal vaccine (group a, c, y and w-135) combined vaccine -1 dose of 0.5ml, injection methyl prednisolone sodium succinate 40 mg, injection pottasium chloride 10 ml., injection morphine 10mg, 1ml, injection balance salt sotution (type- a autoclavable, glass bottle) presterile, for intraocular use 500ml, injection aqueous crystalline penicillin g - 10 lakh unit, injection tropicamide 0.2 mg / ml , phenlyephrine hydrochloride 3.1 mg /ml, lidocaine hydrochloride 10 mg / ml for intracameral use (preservative free, presterile), injection adalimumab 40 mg, injection methyl prednisolone sodium succinate 125 mg, injection omalizumab 150 mg, injection ceftazidime plusavibactam 2.5gm, injection ethamsylate 500mg, injection ethamsylate 250mg, lnjection plasma derived activated prothrombin complex concentrate (1000 units/vial), injection isobaric bupivacaine, injection sugamadex 100mg, lnjection olanzapine 300 mg, injection olanzapine 210 mg, injection methylcobalamine 500 mcg/ml, recombinant anti- d immunoglobuline human 150 mcg vial/pfs injection, recombinant anti- d immunoglobuline human 300 mcg vial/pfs injection

Corrigendum

Sr No Corrigendum Date Corrigendum Type New Submission Date
1 N/A 16-Jul-2026
2 N/A 23-Jul-2026
3 N/A 07-Aug-2026

BOQ

Sl. No. Item Name
1nepafenac eyedrops 0.3percent w/v (bak free)
2Fluticasone Nasal Spray 0.05percent w/v
3Polymyxin-B ear drops 10,000 units/mL
4Diclofenac Patch 100 mg
5Ketoralac Patch 30mg (Transdermal)
6Amoxicillin Potassium Clavulanate 228.5mg/5ml Syrup (30ml)
7Amoxycillin (400mg/5ml) plusClavulanic Acid (57mg/5ml) Drops
8Eye Drop Brinzolamide 1percent W/V and Timolol 0.5percent W/V
9Lotepredenol etabonate eyedrops 0.5percent W/V
10Sodium chloride 5percent eye drops W/V
11Chloramphenicol 1percent W/W, Polymixin B sulphate 5000IU, Dexamethasone sodium phosphate 0.1percentW/W eye ointment
12Eye Drop Brimonidine 0.1percent W/V
13Sodium chromoglycate eyedrops 4percent W/V
14Azithromycin Opthalmic Ointment 1percent W/W 5gm
15Clindamycin Cream
16Sodium Phosphate (Proctolysis ) Enema 100 ml
17Distilled water for humidifier
18Respules Formoterol Fumarate Dihydrate 20 mcg plusMicronised Budesonide 0.5 mg
19Levosalbutamol Inhalation Solution (0.63 mg per 2.5 ml)
20Levosalbutamol Inhalation Solution (1.25 mg)
21Levosalbutamol Metered dose inhaler (50 mcg )
22Levosalbutamol dry powder inhaler (100 mcg)
23Budesonide 400 mcg dry powder inhaler
24Furosemide Drops
25Tablets Isoxsuprine 10mg
26Tablet Artesunate, Pyrimethamine andSulphadoxine 150 mg plus 25 mg plus 500 mg (2) (9-14 years)
27Tablet Linagliptin 2.5 mg
28Tablet Sitagliptin 50 mg
29STI/ RTI colour coded drug kit-8(Tablet Cefixime 800 mg STAT dose and Tab. Doxycycline 100 mg)
30Tablet Pirfenidone 200 mg
31Tablet Pirfenidone 400 mg
32Tablet Nintendanib 100 mg
33Tablet Nintendanib 150 mg
34Tablet Darunavir 600mg
35Tablet Dolutegravir 50mg
36Tablet Dolutegravir 10mg
37Tablet Dolutegravir 50mg +Lamivudine 300mg +Tenofovir 300mg
38Tablet Thiocochicoside 8mg
39Tablet Piroxicam 20mg
40Tablet Mefenamic Acid 500 mg
41Tablet Mycophenolate 250 mg
42Diclofenec Sodium Suppository 25 mg
43Tablet Ketoralac 10 mg
44Doxylamine and vitamin B6 (pyridoxine)
45Tablet Methylcobalamine sublingual 1500 mcg
46Tablet Cilostazol 50 mg
47Tablet Prednisolone 40 mg
48Micropized Progesterone Sustain Released tablets 300mg
49Tablet Ferrous Bisglycinate 25 mg
50Liposomal Iron pyrophosphate 30mg with vitamin C 35 mg, Vitamin B12 0.5 mcg, Folic Acid 570 mcg
51Glycopyronium 25microgram per 2 ml
52Diclofenec Suppository 100 MG
53Injection Isoxsuprine HCl, 5 mg/ml, 2 ml Amp
54Meningococcal Vaccine (Group A, C, Y and W-135) Combined Vaccine -1 Dose of 0.5ml
55Injection Methyl Prednisolone Sodium Succinate 40 mg
56Injection Pottasium Chloride 10 ml.
57Injection Morphine 10mg, 1ml
58Injection Balance Salt Sotution (Type- A Autoclavable, Glass bottle) presterile, for Intraocular use 500ml
59Injection Aqueous Crystalline Penicillin G - 10 lakh unit
60Injection Tropicamide 0.2 mg / ml , Phenlyephrine hydrochloride 3.1 mg /ml, lidocaine hydrochloride 10 mg / ml for intracameral use (Preservative free, presterile)
61Injection Adalimumab 40 mg
62Injection Methyl Prednisolone Sodium Succinate 125 mg
63Injection Omalizumab 150 mg
64Injection Ceftazidime plusAvibactam 2.5gm
65Injection Ethamsylate 500mg
66Injection Ethamsylate 250mg
67lnjection Plasma Derived Activated Prothrombin Complex Concentrate (1000 Units/Vial)
68Injection Isobaric bupivacaine
69Injection Sugamadex 100mg
70lnjection Olanzapine 300 mg
71Injection Olanzapine 210 mg
72Injection Methylcobalamine 500 mcg/ml
73Recombinant Anti- D Immunoglobuline Human 150 mcg vial/pfs Injection
74Recombinant Anti- D Immunoglobuline Human 300 mcg vial/pfs Injection

AI Tender Summary

OUR REF NO 56009448
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 07-08-2026
Authority
Authority Name Gujarat Medical Services Corporation Limited
Work Description T.E.NO.GMSCL/D-791/RC/2026-27 TABLET CAPSULE,INJECTION,MISSELENEOUS ITEMS (74 ITEMS)- nepafenac eyedrops 0.3percent w/v (bak free), fluticasone nasal spray 0.05percent w/v, polymyxin-b ear drops 10,000 units/ml, diclofenac patch 100 mg, ketoralac patch 30mg (transdermal), amoxicillin potassium clavulanate 228.5mg/5ml syrup (30ml), amoxycillin (400mg/5ml) plusclavulanic acid (57mg/5ml) drops, eye drop brinzolamide 1percent w/v and timolol 0.5percent w/v, lotepredenol etabonate eyedrops 0.5percent w/v, sodium chloride 5percent eye drops w/v, chlor henicol 1percent w/w, polymixin b sulphate 5000iu, dexamethasone sodium phosphate 0.1percentw/w eye ointment, eye drop brimonidine 0.1percent w/v, sodium chromoglycate eyedrops 4percent w/v, azithromycin opthalmic ointment 1percent w/w 5gm, clindamycin cream, sodium phosphate (proctolysis ) enema 100 ml, distilled water for humidifier, respules formoterol fumarate dihydrate 20 mcg plusmicronised budesonide 0.5 mg, levosalbutamol inhalation solution (0.63 mg per 2.5 ml), levosalbutamol inhalation solution (1.25 mg), levosalbutamol metered dose inhaler (50 mcg ), levosalbutamol dry powder inhaler (100 mcg), budesonide 400 mcg dry powder inhaler, furosemide drops, tablets isoxsuprine 10mg, tablet artesunate, pyrimethamine andsulphadoxine 150 mg plus 25 mg plus 500 mg (2) (9-14 years), tablet linagliptin 2.5 mg, tablet sitagliptin 50 mg, sti/ rti colour coded drug kit-8(tablet cefixime 800 mg stat dose and tab. doxycycline 100 mg), tablet pirfenidone 200 mg, tablet pirfenidone 400 mg, tablet nintendanib 100 mg, tablet nintendanib 150 mg, tablet darunavir 600mg, tablet dolutegravir 50mg, tablet dolutegravir 10mg, tablet dolutegravir 50mg +lamivudine 300mg +tenofovir 300mg, tablet thiocochicoside 8mg, tablet piroxicam 20mg, tablet mefenamic acid 500 mg, tablet mycophenolate 250 mg, diclofenec sodium suppository 25 mg, tablet ketoralac 10 mg, doxylamine and vitamin b6 (pyridoxine), tablet methylcobalamine sublingual 1500 mcg, tablet cilostazol 50 mg, tablet prednisolone 40 mg, micropized progesterone sustain released tablets 300mg, tablet ferrous bisglycinate 25 mg, liposomal iron pyrophosphate 30mg with vitamin c 35 mg, vitamin b12 0.5 mcg, folic acid 570 mcg, glycopyronium 25microgram per 2 ml, diclofenec suppository 100 mg, injection isoxsuprine hcl, 5 mg/ml, 2 ml , meningococcal vaccine (group a, c, y and w-135) combined vaccine -1 dose of 0.5ml, injection methyl prednisolone sodium succinate 40 mg, injection pottasium chloride 10 ml., injection morphine 10mg, 1ml, injection balance salt sotution (type- a autoclavable, glass bottle) presterile, for intraocular use 500ml, injection aqueous crystalline penicillin g - 10 lakh unit, injection tropicamide 0.2 mg / ml , phenlyephrine hydrochloride 3.1 mg /ml, lidocaine hydrochloride 10 mg / ml for intracameral use (preservative free, presterile), injection adalimumab 40 mg, injection methyl prednisolone sodium succinate 125 mg, injection omalizumab 150 mg, injection ceftazidime plusavibactam 2.5gm, injection ethamsylate 500mg, injection ethamsylate 250mg, lnjection plasma derived activated prothrombin complex concentrate (1000 units/vial), injection isobaric bupivacaine, injection sugamadex 100mg, lnjection olanzapine 300 mg, injection olanzapine 210 mg, injection methylcobalamine 500 mcg/ml, recombinant anti- d immunoglobuline human 150 mcg vial/pfs injection, recombinant anti- d immunoglobuline human 300 mcg vial/pfs injection
Basic Detail
Tender No T.E.NO.GMSCL/D-791/RC/2026-27
Bidding Type Tender
Location
City Gandhinagar
State Gujarat
Key Dates
Publish Date 01 Jan 0001
Submission Date 07 Aug 2026
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee 17700
EMD Ref. Documents
Exemption Not Available
Document List
4e57d32330da4393a39b9308355d3092.html
AgreementandBankGuarantee.pdf
DebarmentPolicy.pdf
EMDGRlistofbank20261.pdf
RateContractTermsandCondition.pdf
TenderDocument791.pdf
TenderNotice791.pdf
TenderSchedule791.pdf

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Aug 01, 2026
11:30 IST

Tender Published

Tender notice published.

Today
Jul 16, 2026
18:00 IST

Corrigendum-1 Issued

Clarifications on tender conditions and amendments issued.

Completed
Jul 23, 2026
18:00 IST

Corrigendum-2 Issued

Clarifications on tender conditions and amendments issued.

Completed
Aug 07, 2026
18:00 IST

Corrigendum-3 Issued

Clarifications on tender conditions and amendments issued.

Upcoming · 6 days
Aug 07, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 6 days

Tender Documents

Download All (ZIP) ↓
html

4e57d32330da4393a39b9308355d3092.html

pdf

AgreementandBankGuarantee.pdf

pdf

DebarmentPolicy.pdf

pdf

EMDGRlistofbank20261.pdf

pdf

RateContractTermsandCondition.pdf

pdf

TenderDocument791.pdf

pdf

TenderNotice791.pdf

pdf

TenderSchedule791.pdf

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders